Skip to main content
Top
Published in: BMC Psychiatry 1/2018

Open Access 01-12-2018 | Research article

An evaluation of functional mental capacity in forensic mental health practice: the Dundrum capacity ladders validation study

Authors: Gearoid Moynihan, Ken O’Reilly, Jane O’Connor, Harry G. Kennedy

Published in: BMC Psychiatry | Issue 1/2018

Login to get access

Abstract

Background

Because of the potential gravity of finding a person incompetent, assessment of mental capacity is challenging for clinicians. We aimed to test validity of a new structured professional judgement tool designed to assess functional mental capacity in three domains – finances, welfare and healthcare.

Methods

Fifty-five male forensic psychiatric patients with Schizophrenia were interviewed using the Dundrum Capacity Ladders – a new semi-structured interview, and scores were assigned on a stratified scoring system, measuring ability to understand, reason, appreciate the personal importance of the decision at hand and communicate a decision. Data were also gathered pertaining to level of therapeutic security at the time of interview, diagnosis, neurocognitive function and a validated measure of real world function.

Results

The results show that internal consistency and inter-rater reliability were high for all items. There were correlations between higher scores of functional mental capacity, neurocognitive function and measures of real world function in this population. Correlations were in the range 0.358 to 0.693, effect sizes that were moderate to high.

Conclusions

The DUNDRUM Capacity Ladders appear to be a valid measure of functional mental capacity in this population. Further prospective studies of functional mental capacity as a measure of recovery are now required.
Literature
1.
go back to reference Schneider C. The Practice of Autonomy. New York, NY; Oxford university press; 1998. Schneider C. The Practice of Autonomy. New York, NY; Oxford university press; 1998.
2.
go back to reference Kahn RS, Keefe RS. Schizophrenia is a cognitive illness: time for a change in focus. JAMA Psychiatry. 2013;70(10):1107–12.CrossRefPubMed Kahn RS, Keefe RS. Schizophrenia is a cognitive illness: time for a change in focus. JAMA Psychiatry. 2013;70(10):1107–12.CrossRefPubMed
3.
go back to reference Grisso T, Appelbaum PS. Assessing Competence to Consent to Treatment: A Guide for Physicians and Other Health Professionals. New York, NY; Oxford university press; 1998. Grisso T, Appelbaum PS. Assessing Competence to Consent to Treatment: A Guide for Physicians and Other Health Professionals. New York, NY; Oxford university press; 1998.
4.
go back to reference UN General Assembly, Universal Declaration of Human Rights, 10 December 1948, 217 A (III). UN General Assembly, Universal Declaration of Human Rights, 10 December 1948, 217 A (III).
5.
go back to reference UN General Assembly, Convention on the Rights of Persons with Disabilities: resolution / adopted by the General Assembly, 24 January 2007, A/RES/61/106. UN General Assembly, Convention on the Rights of Persons with Disabilities: resolution / adopted by the General Assembly, 24 January 2007, A/RES/61/106.
6.
go back to reference Adults with Incapacity (Scotland) Act 2000 (2000 asp 4). Adults with Incapacity (Scotland) Act 2000 (2000 asp 4).
7.
8.
go back to reference Health Care Consent Act, 1996, S.O. 1996, c 2. Sched. A Health Care Consent Act, 1996, S.O. 1996, c 2. Sched. A
9.
10.
go back to reference Assisted Decision Making (Capacity) Act, 2015. Assisted Decision Making (Capacity) Act, 2015.
14.
go back to reference Lysaker PH, Shea AM, Buck KD, Dimaggio G, Nicolò G, Procacci M, Salvatore G, Rand KL. Metacognition as a mediator of the effects of impairments in neurocognition on social function in schizophrenia spectrum disorders. Acta Psychiatr Scand. 2010;122:405–13.CrossRefPubMed Lysaker PH, Shea AM, Buck KD, Dimaggio G, Nicolò G, Procacci M, Salvatore G, Rand KL. Metacognition as a mediator of the effects of impairments in neurocognition on social function in schizophrenia spectrum disorders. Acta Psychiatr Scand. 2010;122:405–13.CrossRefPubMed
15.
16.
go back to reference Volicer L, Ganzini L. Health professionals’ views on standards for decision-making capacity regarding refusal of medical treatment in mild Alzheimer’s disease. J Am Geriatr Soc. 2003;51(9):1270–4.CrossRefPubMed Volicer L, Ganzini L. Health professionals’ views on standards for decision-making capacity regarding refusal of medical treatment in mild Alzheimer’s disease. J Am Geriatr Soc. 2003;51(9):1270–4.CrossRefPubMed
17.
go back to reference Marson DC, McInturff B, Hawkins L, Bartolucci A, Harrel LE. Consistency of physician judgements of capacity to consent in mild Alzheimer’s disease. J Am Geriatr Soc. 1997;45(4):453–7.CrossRefPubMed Marson DC, McInturff B, Hawkins L, Bartolucci A, Harrel LE. Consistency of physician judgements of capacity to consent in mild Alzheimer’s disease. J Am Geriatr Soc. 1997;45(4):453–7.CrossRefPubMed
18.
go back to reference Canterbury v Spence (464 F.2d 772, 782 D.C. Cir. 1972) Canterbury v Spence (464 F.2d 772, 782 D.C. Cir. 1972)
19.
20.
go back to reference Kennedy M, Dornan J, Rutledge E, O’Neill H, Kennedy HG. Extra information about treatment is too much for the patient with psychosis. Int J Law Psychiatry. 2009;32(6):369–76.CrossRefPubMed Kennedy M, Dornan J, Rutledge E, O’Neill H, Kennedy HG. Extra information about treatment is too much for the patient with psychosis. Int J Law Psychiatry. 2009;32(6):369–76.CrossRefPubMed
21.
go back to reference Gigerenzer G, Selten R. Bounded Rationality: The adaptive toolbox. Cambridge, MA; the MIT Press; 2001. Gigerenzer G, Selten R. Bounded Rationality: The adaptive toolbox. Cambridge, MA; the MIT Press; 2001.
22.
go back to reference Grisso T, Applebaum PS, Hill-Fotouhi C. The MacCat-T: a clinical tool to assess patients’ capacities to make treatment decisions. Psychiatr Serv. 1997;48(11):1415–9.CrossRefPubMed Grisso T, Applebaum PS, Hill-Fotouhi C. The MacCat-T: a clinical tool to assess patients’ capacities to make treatment decisions. Psychiatr Serv. 1997;48(11):1415–9.CrossRefPubMed
23.
go back to reference Akinkunmi AA. The MacArthur competence assessment tool – fitness to plead: a preliminary evaluation of a research instrument for assessing fitness to plead in England and Wales. J Am Acad Psychiatry Law. 2002;30(4):476–82.PubMed Akinkunmi AA. The MacArthur competence assessment tool – fitness to plead: a preliminary evaluation of a research instrument for assessing fitness to plead in England and Wales. J Am Acad Psychiatry Law. 2002;30(4):476–82.PubMed
24.
go back to reference Janofsky JS, McCarthy RJ, Folstein MF. The Hopkins competency assessment test: a brief method for evaluating patients’ capacity to give informed consent. Hosp Community Psychiatry. 1992;43(2):132–6.PubMed Janofsky JS, McCarthy RJ, Folstein MF. The Hopkins competency assessment test: a brief method for evaluating patients’ capacity to give informed consent. Hosp Community Psychiatry. 1992;43(2):132–6.PubMed
25.
go back to reference Fazel S, Hope T, Jacoby R. Assessment of competence to complete advance directives: validation of a patient centred approach. BMJ. 1999;318(7182):493–7.CrossRefPubMedPubMedCentral Fazel S, Hope T, Jacoby R. Assessment of competence to complete advance directives: validation of a patient centred approach. BMJ. 1999;318(7182):493–7.CrossRefPubMedPubMedCentral
26.
go back to reference Naughton M, Nulty A, Abidin Z, Davoren M, O'Dwyer S, Kennedy HG. Effects of group meta-cognitive training (MCT) on mental capacity and functioning in patients with psychosis in a secure forensic psychiatric hospital: a prospective-cohort waiting list controlled study. BMC Research Notes. 2012;5:302.CrossRefPubMedPubMedCentral Naughton M, Nulty A, Abidin Z, Davoren M, O'Dwyer S, Kennedy HG. Effects of group meta-cognitive training (MCT) on mental capacity and functioning in patients with psychosis in a secure forensic psychiatric hospital: a prospective-cohort waiting list controlled study. BMC Research Notes. 2012;5:302.CrossRefPubMedPubMedCentral
28.
30.
go back to reference Pillay SM, Oliver B, Butler L, Kennedy HG. Risk stratification and the care pathway. Ir J Psychol Med. 2008;25(4):123–7.CrossRef Pillay SM, Oliver B, Butler L, Kennedy HG. Risk stratification and the care pathway. Ir J Psychol Med. 2008;25(4):123–7.CrossRef
31.
go back to reference First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P). New York: Biometrics Research, New York State Psychiatric Institute; 2002. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P). New York: Biometrics Research, New York State Psychiatric Institute; 2002.
32.
go back to reference Niv N, Cohen AN, Sullivan G, Young AS. The MIRECC version of the global assessment of functioning scale: reliability and validity. Psychiatr Serv. 2007;58(4):529–35.CrossRefPubMed Niv N, Cohen AN, Sullivan G, Young AS. The MIRECC version of the global assessment of functioning scale: reliability and validity. Psychiatr Serv. 2007;58(4):529–35.CrossRefPubMed
33.
go back to reference Nuechterlein KH, Green MF, Kern RS, et al. The MATRICS consensus cognitive battery, part 1: test selection, reliability, and validity. Am J Psychiatry. 2008;165(2):203–13.CrossRefPubMed Nuechterlein KH, Green MF, Kern RS, et al. The MATRICS consensus cognitive battery, part 1: test selection, reliability, and validity. Am J Psychiatry. 2008;165(2):203–13.CrossRefPubMed
35.
go back to reference Moser DJ, Schultz SK, Arndt S, et al. Capacity to provide informed consent for participation in schizophrenia and HIV research. Am J Psychiatry. 2002;159(7):1201–7.CrossRefPubMed Moser DJ, Schultz SK, Arndt S, et al. Capacity to provide informed consent for participation in schizophrenia and HIV research. Am J Psychiatry. 2002;159(7):1201–7.CrossRefPubMed
36.
go back to reference Dornan J, Kennedy M, Garland J, Rutledge E, Kennedy HG. Functional mental capacity, treatment as usual and time: magnitude of change in secure hospital patients with major mental illness. BMC Res Notes. 2015(14); 8:566. Dornan J, Kennedy M, Garland J, Rutledge E, Kennedy HG. Functional mental capacity, treatment as usual and time: magnitude of change in secure hospital patients with major mental illness. BMC Res Notes. 2015(14); 8:566.
37.
go back to reference Keefe RS, Bilder RM, Davis SM, et al. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial. Catie investigators; neurocognitive working group. Arch Gen Psychiatry. 2007;64:633–47.CrossRefPubMed Keefe RS, Bilder RM, Davis SM, et al. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial. Catie investigators; neurocognitive working group. Arch Gen Psychiatry. 2007;64:633–47.CrossRefPubMed
38.
go back to reference O’Reilly K, Donohoe G, O’Sullivan D, et al. Study protocol: a randomised controlled trial of cognitive remediation for a national cohort of forensic mental health patients with schizophrenia of schizoaffective disorder. BMC Psychiatry. 2016;16:5.CrossRefPubMedPubMedCentral O’Reilly K, Donohoe G, O’Sullivan D, et al. Study protocol: a randomised controlled trial of cognitive remediation for a national cohort of forensic mental health patients with schizophrenia of schizoaffective disorder. BMC Psychiatry. 2016;16:5.CrossRefPubMedPubMedCentral
39.
go back to reference O’Reilly K, O’Connell P, Donohoe G, et al. Anticholinergic burden in schizophrenia and ability to benefit from psychosocial treatment programmes: a 3-year prospective cohort study. Psychol Med. 2016;46(15):3199–211.CrossRefPubMed O’Reilly K, O’Connell P, Donohoe G, et al. Anticholinergic burden in schizophrenia and ability to benefit from psychosocial treatment programmes: a 3-year prospective cohort study. Psychol Med. 2016;46(15):3199–211.CrossRefPubMed
40.
go back to reference Karow A, Moritz S, Lambert M, Schöttle D, Naber D. On behalf of the EGOFORS initiative. Remitted but still impaired? Symptomatic versus functional remission in patients with schizophrenia. Eur Psychiatry. 2012;27:401–5.CrossRefPubMed Karow A, Moritz S, Lambert M, Schöttle D, Naber D. On behalf of the EGOFORS initiative. Remitted but still impaired? Symptomatic versus functional remission in patients with schizophrenia. Eur Psychiatry. 2012;27:401–5.CrossRefPubMed
41.
go back to reference Schennach-Wolff R, Jäger M, Seemüller F, et al. Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders. Schizophr Res. 2009;113(2–3):210–7.CrossRefPubMed Schennach-Wolff R, Jäger M, Seemüller F, et al. Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders. Schizophr Res. 2009;113(2–3):210–7.CrossRefPubMed
Metadata
Title
An evaluation of functional mental capacity in forensic mental health practice: the Dundrum capacity ladders validation study
Authors
Gearoid Moynihan
Ken O’Reilly
Jane O’Connor
Harry G. Kennedy
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2018
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-018-1658-2

Other articles of this Issue 1/2018

BMC Psychiatry 1/2018 Go to the issue